ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
In Situ Electrically Resettable Field-Effect Transistor Biosensors for Continuous and Multiplexed Neurotransmitter Detection.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Nucleic acid aptamers: new methods for selection, target validation, molecular diagnostics and therapeutics.Signal transduction and targeted therapy · 2026Review
- Nucleic Acid-Based Field-Effect Transistor Biosensors.Biosensors · 2026Review
- In Situ Electrically Resettable Field-Effect Transistor Biosensors for Continuous and Multiplexed Neurotransmitter Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Accurate, real-time detection of neurotransmitters is crucial for elucidating the mechanisms of brain function and tracking the progression of neurological diseases. Biosensors usually face poor reusability induced by difficulties in probe-target separation, hindering their application for continuous monitoring. In this work, a semiconducting carbon nanotube (CNT) film field-effect transistor (FET) biosensor is developed using pH-sensitive aptamers as probes to capture targets. Through tuning the potential of on-chip palladium electrodes, the biosensor facilitates in situ pH modulation and recovery of the sensor interface, which enables an electrically resettable biosensor. The fabricated sensor demonstrates exceptional sensitivity (with femtomolar-level detection limits), high selectivity (specific responses are 20 times stronger than non-specific ones), and excellent reusability (over ten reuse cycles). Furthermore, in vitro detection demonstrates that the biosensor arrays, incorporating regional modifications and pH-sensitive probes, enable the simultaneous detection of several neurotransmitters, including dopamine, serotonin, histamine, and glutamate in complex biological samples. The combination of microfluidic techniques further lowers non-specific adsorption and cross-reactivity, ensuring reliable, repeatable real-time detection. The resettable CNT FET biosensor array holds significant promise for advancing the monitoring of neurotransmitter dynamics, serving as a powerful tool for the early diagnosis and management of neurological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.